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Multiscale QM/MM Simulations of ATP Hydrolysis Mechanism in ABC-
Transporters
Jingzhi Pu.
Dept. of Chem. & Chem. Biol., Indiana Univ.-Purdue Univ. Indianapolis,
Indianapolis, IN, USA.
Adenosine triphosphate (ATP) binding cassette (ABC) transporters are ubiqui-
tous molecular motor proteins that translocate various substrates across cell
membranes at the expense of ATP hydrolysis. Although it is known that
nucleotide binding domains in ABC-transporters contain a collection of char-
acteristic sequence motifs, the precise mechanism under which ATP is hydro-
lyzed in these systems remains unknown. By using multiscale combined
quantum mechanical and molecular mechanical (QM/MM) free energy simula-
tions, we examined several possible ATP hydrolysis mechanisms in members
of ABC-transporters. Our results reveal how the active site residues may partic-
ipate in the catalytic mechanism and how protein dynamics may contribute to
catalysis.
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Reconstitution of Multidrug Resistance Efflux Pumps in Giant Liposomes
SooHyun Park, You Jung Kang, Sheereen Majd.
Biomedical Engineering, Pennsylvania State University, University Park,
PA, USA.
Multidrug resistance (MDR), a phenomenon in which cells become resistant to
a number of drugs, is a growing obstacle for treatment of cancer and bacterial
infections. A group of membrane transporters, known as MDR efflux pumps
that bind to a wide range of foreign molecules and pump them out of the
cell, are suspected to be the main contributors to MDR. P-glycoprotein
(Pgp), which is the most well studied MDR efflux pump, has a critical role
in the distribution of drugs in the body. As a result, screening the interactions
between this protein and candidate drugs has recently become a required step in
the FDA approval process. Biophysical characterization of Pgp and its transport
activity may provide key information for the design and development of effec-
tive therapeutics. Giant unilamellar vesicles (GUV) are excellent models for
natural cell membranes and present appealing platforms for biophysical studies
of Pgp under well-defined conditions. Here, we reconstitute Pgp from Chinese
hamster ovary B30 cells in giant unilamellar vesicles and investigate its
ATPase activity as well as its transport activity.
In this study, we applied small proteoliposomes with reconstituted Pgp for
electroformation of Pgp-containing giant vesicles via our recently reported
technique of hydrogel-assisted electroformation. These electroformed giant
vesicles were characterized using fluorescence microscopy, immunohisto-
chemistry, and ATPase assays. Fluorescence immunostaining confirmed the
presence of Pgp in the membrane of GUVs. ATPase assay demonstrated that
Pgp in GUVs retained its ATPase activity upon electroformtion. The specific
ATPase activity of Pgp in GUVs was about 640 nmol/mg,min, comparable
to that of this protein in small proteoliposomes, ~660 nmol/mg,min. Moreover,
we are investigating the transport activity of Pgp in these giant liposomes using
fluorescence microscopy. The present study may provide valuable insight to the
function of this MDR efflux pump.
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Exploring P-Glycoprotein Substrate Access
Laura Domicevica, Philip C. Biggin.
Department of Biochemistry, University of Oxford, Oxford, United
Kingdom.
P-glycoprotein (P-gp), an ATP Binding Cassette transporter family membrane
protein, extrudes mainly hydrophobic substrates in an ATP hydrolysis-
dependant manner. Structurally, P-gp consists of two transmembrane domains
(TMD) each comprised of 6 a-helices that together form the drug binding site,
and two nucleotide binding domains (NBD) that via ATP binding and hydroly-
sis provide the energy for the conformational changes necessary to drive drug
translocation.
Due to the wide variety of substrates it extrudes, P-gp is one of the main causes
of multidrug resistance in cancer and other diseases. As multidrug resistance
becomes an ever increasingly important issue, drug development is dependant
on knowing what constitutes the difference between a substrate and a non-
substrate of P-gp. Although the chemical structure is likely to play a role in
recognition within the binding site, it is equally important to understand how
access to the binding site is controlled. Therefore more information about
way in which substrates access the binding site is of key interest.
In the absence of a human P-gp crystal structure, several human homology
models were made from both eukaryotic and bacterial homologue crystal struc-
tures. The models were assessed for structural stability and conformational dy-
namics using molecular dynamics (MD) simulations. Following analysis, thehomology model from the C. elegans template was chosen as the model for
steered MD calculations to investigate possible substrate access pathways.
The results, when combined with bilayer localisation NMR experiments and
MD simulations, give novel insights into the factors that govern P-gp substrate
specificity.
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Methionine Importers in Soil Bacteria: Potential for Transporter-
Component Crosstalk
Eliza Zielazinski, Sarah Zerbs, Peter Larsen, Frank Collart, Philip D. Laible.
Biosciences Division, Argonne National Laboratory, Lemont, IL, USA.
ABC transporters are widely distributed amongst kingdoms and are responsible
for nutrient transport across cellular membranes. Certain soil bacteria contain a
higher than average percentage of ABC transporters, representing 40-70% of
encoded transporters. While studies of SBPs have indicated that permeases
can interact with multiple SBPs with varying affinity and specificity, limited in-
formation exists regarding permease specificity for ATPases. The potential for
permeases to interact with multiple ATPases was suggested given the high ge-
netic redundancy of homologous types of ABC transporters in plant growth
promoting bacteria (PGPB). Genomic analyses of four Pseudomas fluorescens
strains identified a tractable set of ABC-type amino acid importers with high
sequence similarity to the structurally characterized E. coli methionine
importer MetNI, sharing the presence of a C-terminal C2 regulatory domain
on the ATPase. This domain inhibits methionine uptake by preventing ATP hy-
drolysis when intracellular methionine is bound.
Using a dual-expression-vector strategy, both native complexes and ‘hybrid’
complexes were stably isolated. Native complexes utilize permease and
ATPase components from an individual operon whereas hybrid complexes
partner a permease domain from one operon with an ATPase domain from
another. Interestingly, three target ATPases from strain PF-5 were able to
form stable complexes with a single PF-5 permease target, suggesting this
strain has high potential for hybrid interactions. These PF-5 hybrid complexes
are shown to be dimers by gel filtration and functional by ATPase assays.
The transinhibition mechanism of the C2 domain was also investigated,
showing that D- and L-methionine differentially inhibit ATP hydrolysis of
PF-5 hybrid complexes. Initial studies of SBPs associated with these complexes
show a correlation between SBP ligands and compounds allosterically inhibit-
ing ATPases. The ability for crosstalk could be especially significant for PGPB,
allowing them to provide rapid and specific nutrient exchange with symbiotic
species.
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EPR Accessibility Measurements of the SERCA-PLB Complex using Site-
Directed Spin Labeling
Peter D. Martin, Zachary M. James, Jesse E. McCaffrey, Dave D. Thomas.
University of Minnesota, Minneapolis, MN, USA.
We investigate the structure formed byof phospholamban (PLB) bound to the
sarcoplasmic reticulum (SR) Ca2þ-ATPase (SERCA) using site-directed spin
labeling. SERCA is a 994 residue transmembrane protein that helps control
Ca2þ concentration in the SR relative to the cytoplasm in order to facilitate
muscle relaxation. PLB is a 52 residue regulatory muscle protein found in car-
diac muscle which, upon binding, has been shown to inhibit SERCA activity.
However, phosphorylation of PLB at Ser-16 partially relieves this inhibition
while still maintaining a combined structureconserving the complex. The struc-
tural mechanism behind this relief of inhibition is largely unknown. Using EPR
accessibility measurements, we have shown that phosphorylation of PLB at
Ser-16 alters the binding interface between its transmembrane helix and the
PLB binding groove on SERCA, likely breaking the interactions that lead to
inhibition.
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Mapping of Sarcolipin Conformational States along the Enzymatic
Pathway of SERCA
Alysha A. Dicke1, Kaustubh R. Mote2, Gianluigi Veglia1.
1BMBB, University of Minnesota, Minneapolis, MN, USA, 2TIFR Center for
Interdisciplinary Sciences, Narsinghi, India.
Sarcolipin (SLN), a 31 amino acid transmembrane peptide, binds to the
Sarco(endo)plasmic Reticulum Ca2þ ATPase (SERCA) decreasing its
apparent Ca2þ affinity. SERCA pumps Ca2þ from the cytoplasm of muscle
cells into the sarcoplasmic reticulum (SR) using energy derived from ATP hy-
drolysis. This re-establishes the Ca2þ gradients needed for normal muscle
function. Phosphorylation of SLN relieves the inhibition of SERCA and
may be involved in the beta-adrenergic response. Although a significant
amount is known about SERCA, and many of the conformations throughout
its transport cycle have been crystallized, the mechanism of how SLN de-
creases SERCA’s Ca2þ affinity and alters the coupling between ATP
Sunday, February 8, 2015 147ahydrolysis and Ca2þ transport is not well understood. Using solid-state nuclear
magnetic resonance spectroscopy and functional assays, we investigated the
differences in the interaction of phosphorylated SLN with SERCA compared
to non-phosphorylated SLN with SERCA. Previous work in our lab demon-
strates that the topology of SLN in complex with SERCA changes depending
on SERCA’s conformation. As such, continuing work involves mapping the
structural changes of phosphorylated SLN with the various conformations of
SERCA. Overall, gaining a better understanding of how SERCA is regulated
will add in the development of therapies for diseases resulting from improper
calcium cycling.
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Using a Live-Cell High-Throughput Time-Resolved FRET Assay to
Discover Enzyme Modulators
Ji Li1, Tory M. Schaaf1, Simon J. Gruber1, Razvan L. Cornea1,
Joseph M. Autry1, Samantha L. Yuen1, Ryan Chen1, Kurt C. Peterson2,
Gregory D. Gillispie1,2, David D. Thomas1.
1Biochemsitry, Molecular Biology, and Biophysics, University of Minnesota,
Minneapolis, MN, USA, 2Fluorescence Innovations, Inc, Minneapolis,
MN, USA.
We developed a high-precision high-throughput live-cell assay to screen for
small molecules that activate the non-muscle sarco/endo-plasmic reticulum
calcium ATPase (SERCA2b) using a ‘‘2-color’’ SERCA2b biosensor and
a fluorescence-lifetime plate reader (FLT-PR). The 2-color SERCA2b
(h2CS2b) biosensor was derived from a human pancreatic SERCA isoform,
in which red fluorescent protein (mRuby2) was fused to the N terminus and
green fluorescent protein (Clover) to an interior loop. A HEK cell line
expressing the h2CS2b biosensors maintained stable expression level of the
biosensors for several tens of passages, ideal for large scale HTS campaigns.
This biosensor, upon binding of SERCA2b effectors, translates the minute
SERCA structural rearrangements into small changes of intramolecular
FRET that can only be reliably detected using fluorescence lifetime (FLT).
The h2CS2b biosensor provided dose-dependent FRET changes in response
to SERCA inhibitors such as thapsigargin, CPA, and BHQ, and SERCA
activators previously discovered in this lab. Two instruments developed by
Fluorescence Innovations were crucial for this work: a FLT plate reader,
which provides a 30-fold increase of precision compared to conventional
intensity-based instruments, and a high-speed fluorescence-spectra plate
reader, which was used to filter out artifacts due to compound fluorescence.
We screened a commercial chemical library of 50000 compounds and
identified 94 compounds that significantly affect 2-color SERCA fluorescence
lifetime. Functional assays are underway to evaluate the biochemical
properties of these small molecules, and their potential for therapeutic appli-
cation in diabetes and heart failure. This type of assay is being applied to
several other drug targets, with promising results. This work was funded
by NIH grants to DDT (R01 GM27906, P30 AR0507220), and to GDG
(STTR,5R41DA037622-02).
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Molecular Dynamics Simulations of Calcium Pump Structural Disorder
Nikolai Smolin, Seth Robia.
Department of Cell and Molecular Physiology, Loyola University Chicago,
Maywood, IL, USA.
To characterize the conformational dynamics of sarcoplasmic reticulum (SR)
calcium pump (SERCA) we performed molecular dynamics simulations begin-
ning with several different high-resolution structures. We quantified differ-
ences in structural disorder and dynamics for an open E1 conformation of
SERCA (pdb: 1SU4) versus closed E2 structures (pdb: 2ZBD, 1WPG), and
observed that dynamic motions of SERCA cytoplasmic domains increased
with domain-domain separation distance. The results are useful for interpreta-
tion of recent intramolecular Fo¨rster resonance energy transfer (FRET) distance
constraints obtained for SERCA fused to fluorescent protein tags. Those previ-
ous physical measurements quantified the population of discrete structural sub-
states and revealed that open conformations of SERCA are more dynamically
disordered than compact conformations. The present simulations support this
hypothesis and provide additional details of SERCA structural dynamics. Spe-
cifically, all-atoms simulations revealed large scale translational and rotational
motions of the SERCA N-, A- and P-domains. We also observed a transition
from an open to a closed headpiece conformation over the course of a 400 ns
trajectory. Intermediate structures sampled during the open-to-closed transition
were long lived, with >50 ns dwell times observed for each conformation. We
observed well-resolved peaks in a histogram of calculated domain separation
distances, consistent with saltatory transitions between discrete conformational
substates. The open-to-closed conformational transition was mediated in part
by an initial interaction of an N-domain loop (Nbeta5-beta6, residues 426-436) that formed dynamic H-bonds with residues 133-139 of the A-domain.
The propensity for domain closure was increased by pre-alignment of
H-bonding residues and decreased by mutation of these residues to Ala. Overall
the data suggest that N-domain loop residues are particularly important for
mediating the transition through several novel structural substates during the
closure of the SERCA cytoplasmic headpiece.
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Exploring Cardiac Calcium ATPase Dimerization
Daniel Blackwell, Seth Robia.
Loyola University Chicago, Maywood, IL, USA.
Previous studies have suggested that the cardiac calcium ATPase (SERCA) can
form homo-dimers. To investigate this in heterologous cells, we fused Cerulean
(Cer) or yellow fluorescent protein (YFP) to the N-terminus of canine
SERCA2a. We measured 18% maximum fluorescence resonance energy trans-
fer (FRET) from Cer-SERCA to YFP-SERCA, indicating an interaction be-
tween SERCA protomers. To determine whether the measured FRET was
specific, we co-transfected cells with unlabeled SERCA to compete for binding
with Cer-SERCA and YFP-SERCA. FRET progressively decreased with
increasing molar ratios of unlabeled competitor SERCA to a minimum of
5%. Competition with increasing molar ratios of unlabeled phospholamban
(PLB) did not reduce the measured FRET or the apparent affinity of the SERCA
dimer. In order to determine whether PLB phosphorylation status altered
SERCA dimerization, we enhanced phosphorylation of PLB at serine 16 by fos-
kolin or using a phosphomimetic PLB (S16E). This did not alter the maximum
FRET or the apparent affinity of the SERCA protomers for each other. Addi-
tionally, the apparent affinity was unchanged with various concentrations of
cytosolic calcium or ATP, or in the presence of the SERCA inhibitor, thapsigar-
gin. SERCA dimerization was also suggested by co-immunoprecipitation ex-
periments in cells co-transfected with YFP-SERCA and myc-tagged SERCA.
Immunoprecipitation with an anti-mycTag antibody co-immunoprecipitated
YFP-SERCA, as detected by western blot. To analyze SERCA dimerization
in cardiac myocytes, we used benzophenone-4-maleimide crosslinking. Rabbit
left ventricular myocytes were isolated and permeabilized in the presence of
crosslinker. Western blot analysis revealed two bands: the first at approxi-
mately 110 kD, consistent with monomeric SERCA, and the second at approx-
imately 200 kD, a value compatible with the predicted molecular weight of a
homo-dimer. Our data suggest that SERCA2a forms obligate homo-dimers in
live cells, including cardiac myocytes. We have not determined a regulatory
component for this interaction.
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Functional Analysis of Proton-Transporter at Single Molecule Level
Salome Veshaguri1, Sune M. Christensen1, Garima Ghale1, Mads Møller1,
Christina Lohr1, Andreas Lauge Christensen1, Marijonas Tutkus1,
Gerdi Kemmer2, Bo Højen Justesen2, Ida Louise Jørgensen2,
Thomas Pomorski2, Dimitrios Stamou1.
1Bio-nanotechnology and Nanomedicine Group, University of Copenhagen,
Copenhagen, Denmark, 2Department of Plant and Environmental Sciences,
University of Copenhagen, Copenhagen, Denmark.
Membrane transporters regulate multiple physiological processes including the
pumping of ions, peptides and other metabolites such as neurotransmitters.
Despite plethora of information available on transmembrane transporters, the
possibility that transporters like all other enzymes studied to date display static
and dynamic fluctuations in activity remains open. Importantly we currently
ignore the impact such fluctuation have on the critical issue of pumping stoichi-
ometry and therefore pumping efficiency. For example, several studies on
P-type ATPases suggest substantially less amount of cations being transported
to ATP hydrolyzed, possibly due to uncoupling of ATP-hydrolysis from cation
transport during resting state.(1,2)
Here, we present results from our ongoing investigation on time-resolved
recording of single transporter events, using surface-based arrays of proteolipo-
somes.(3-5) Our single molecule studies have revealed fluctuations (on/off
states) in the activity the P-type Hþ-ATPases-2 from Arabidopsis thaliana
(AHA2). Insights from these on and off activity states for proton transporter
will be used to estimate the true proton to ATP stoichiometry. Preliminary ex-
periments were also performed to understand the role of the regulatory domain
that is thought to be critical in coupling hydrolysis to proton coupling.(6)
References:
(1)Berman, M. C. Biochim. Biophys. Acta 2001, 1513, 95.
(2)Venema, K. et al. J. Biol. Chem. 1995, 270, 19659.
(3)Christensen, S. M. et al. Nat. Nanotechnol. 2012, 7, 51.
(4)Hatzakis, N. S. et al. Nat. Chem. Biol. 2009, 5, 835.
(5)Mathiasen, S. et. al. Nat. Methods 2014, 11, 931.
(6)Pedersen, B. P. et al. Nature 2007, 450, 1111.
